METTL14 and colorectal carcinoma: confirmed that METTL14‐induced m6A mRNA methylation inhibits pri‐miR‐17 mRNA degradation by reducing YTHDC2 recognition of the ‘GGACC’ binding site, regulating mitochondrial function and playing a critical role in CRC resistance to 5‐FU.